Anti-VEGF antibodies and their uses

Details for Australian Patent Application No. 2010262836 (hide)

Owner Abbott Biotherapeutics Corp.

Inventors Harding, Fiona; Akamatsu, Yoshiko; Dubridge, Robert B.; Powers, David B.

Agent Davies Collison Cave

Pub. Number AU-A-2010262836

PCT Pub. Number WO2010/148223

Priority 61/218,005 17.06.09 US

Filing date 17 June 2010

Wipo publication date 23 December 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/148223 Priority application(s): WO2010/148223

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010262843-System and method for performing tomographic image acquisition and reconstruction

2010262823-Controlling ad delivery to mobile clients